Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.
You can purchase shares of Lucid Diagnostics (NASDAQ:LUCD) through any online brokerage.
Other companies in Lucid Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Modular Medical (NASDAQ:MODD) and QT Imaging Holdings (NASDAQ:QTI).
Lucid Diagnostics has a consensus price target of $3.67.
The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.8545 last updated January 10, 2025 at 5:04 PM EST.
There are no upcoming dividends for Lucid Diagnostics.
Lucid Diagnostics’s Q4 earnings are confirmed for Monday, March 24, 2025.
There is no upcoming split for Lucid Diagnostics.
Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.